ArticleScientific reports2025
Comparison of crosslinked and non-crosslinked collagenated xenografts for vertical bone augmentation in rabbit calvaria.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Bovine or porcine xenografts, which are readily available and possess osteoconductivity, are widely used for bone augmentation in clinical practice. The addition of collagen to particulated bone graft material improves handling characteristics and helps maintain graft integrity. These collagenated bone, when collagen is appropriately cross-linked, provide enhanced osteogenic potential and structural stability. However, studies on the histological changes due to the use of collagenated bovine bone for vertical bone augmentation are lacking. Therefore, this study aimed to compare the osteoconductivity and volume stability of two collagenated xenografts-deproteinized bovine bone mineral (DBBM) with crosslinked bovine collagen (DBBM-Cb; A-Oss Collagen) and non-crosslinked porcine collagen (DBBM-NCp; Bio-Oss Collagen)-using rabbit calvarial models of vertical augmentation and critical-sized defects. Surface morphology of the grafts was analyzed using field emission scanning electron microscopy. In vivo bone regeneration was assessed using micro-computed tomography and histological analyses at 3, 5, 6, and 12 weeks following bone grafting in calvarial vertical-augmentation and defect models. Both grafts showed porous and interconnected microarchitecture favorable for osteoconduction. In the augmentation model, DBBM-Cb demonstrated significantly higher bone volume fraction (bone volume/total volume of bone tissue) at 3 weeks and vertical height retention at both 3 and 5 weeks (P < 0.05). In the defect model, DBBM-Cb led to significantly greater defect closure at 12 weeks (P < 0.05). Histological analyses confirmed improved graft integration and bone maturation with DBBM-Cb. DBBM-Cb exhibited superior osteoconductivity, structural stability, and graft volume maintenance compared to DBBM-NCp. These properties support its potential as a more effective biomaterial for vertical bone augmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.